Microscopic polyangiitis
Also known as: MPA, Microscopic polyarteritis, ANCA-associated microscopic polyangiitis
Microscopic polyangiitis (MPA) is an autoimmune small-vessel vasculitis that can lead to significant kidney and lung damage. Diagnosis relies on a combination of clinical assessment, renal investigations, imaging, and often a biopsy; while MPO-ANCA results help with interpretation, they don't confirm the diagnosis on their own. Specialist-led immunosuppressive treatment and regular monitoring are the cornerstones of care. The current research comprises case reports and a retrospective diagnostic study rather than clinical trials for Chinese medicine. There is no evidence that acupuncture or herbal formulas can control MPA, prevent relapse, or protect organs. For patients who are medically stable, traditional pattern assessment might help frame adjunctive support for symptoms like fatigue, appetite, or dryness, provided it never delays medical investigation or interferes with prescribed treatment. Herbs must be used with extreme caution, particularly regarding renal impairment and potential drug interactions.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Adhere strictly to all specialist consultations, pathology monitoring, and prescribed pharmacological regimens as directed by the treating clinician.
- •Comply with specific renal dietary requirements regarding sodium, fluid, and solute intake; avoid non-clinical detoxification protocols or excessive fluid loading.
- •Balance gentle physical activity with rest, pausing and seeking medical advice if new dyspnoea, dizziness, or marked fatigue develops.
- •Cease tobacco use and avoid respiratory irritants; consult the medical team regarding infection prophylaxis and appropriate immunisation scheduling.
Cautions & Contraindications
- •Defer acupuncture and herbal initiation during suspected active lung or kidney deterioration; urgent medical assessment takes priority. The supplied cases support the seriousness of organ involvement, not the safety or efficacy of adjunctive treatments.[,]
- •Do not needle painful flank or abdominal areas when acute bleeding is possible, and do not use symptom relief to delay emergency assessment. This precaution is informed by the reported rare renal haemorrhage, not an acupuncture safety study.[]
- •Do not use ANCA fluorescence patterns alone to label symptoms as relapse or remission, select herbs, or justify reducing immunosuppression; diagnostic interpretation requires clinical context and antigen-specific testing.[]
- •With renal impairment or concurrent immunosuppressants, defer herbal prescribing until the specialist and pharmacist review the full product and medicine list. The supplied reports describe renal injury and conventional treatment but provide no herb–drug safety data.[,,]
When to reassess or seek care again
If medically cleared for adjunctive care, review after 2–4 weeks using baseline and repeat fatigue, appetite, sleep or dryness scores on a 0–10 scale and a simple functional goal such as tolerance of routine daily activities. Record adverse events and medicine changes. Review renal function, urinalysis and other monitoring only in coordination with the specialist; subjective improvement does not establish disease remission. Stop or revise adjunctive care if there is no meaningful symptom benefit by four weeks. New organ symptoms require immediate or same-day referral according to severity, not a scheduled TCM review.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- Pulmonary nodules in a case of microscopic polyangiitis: a case report and review of the literature.Journal of medical case reports · 2026
- Clinical biochemistry · 2026
- Journal of medical cases · 2026
- Medicine · 2025
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
